GA HB1329

Amends Schedule I controlled substances definition to add "alkyl, halide, cyano, or acetyl group" as chemical substitutions at the 5-position or 6-position that qualify a substance for scheduling

Adds approximately 50 new pharmaceutical compounds to Georgia's dangerous drug list, including cancer treatments (Datopotamab deruxtecan-dlnk, Ziftomenib), gene therapies (Onasemnogene abeparvovec-brve), and various biologics and targeted therapies

Updates existing dangerous drug entries for antihemophilic factor, Chikungunya vaccine, and COVID-19 vaccine by removing specific formulation designations

Expands epinephrine exemption to allow pharmacists to distribute devices delivering up to 2 mg of epinephrine for emergency treatment of allergic reactions and anaphylaxis, in addition to the existing 0.125 mg asthma inhaler exemption

Becomes effective upon Governor's approval or upon becoming law without approval